Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advanced MR and PET Imaging in Inflammatory Demyelinating Diseases
NCT05805839Phase 2Enrolling by invitation
- Sponsor
- Mayo Clinic
- Start
- Jul 2023
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 2 trial of [11C]ER176 in multiple sclerosis (MS), Inflammatory demyelinating disease (IDD), sponsored by Mayo Clinic. Started Jul 2023; status: enrolling by invitation.
02
Drugs
[11C]ER176
03
Conditions
multiple sclerosis (MS)Inflammatory demyelinating disease (IDD)
Beyond the preview
Go deeper on NCT05805839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05805839.